Biovest, Max Planck Institute ink viral vaccine manufacturing deal
Under the collaboration, the Max Planck Institute will conduct a series of influenza virus growth studies to determine the advantages of Biovest’s proprietary Hollow Fiber Bioreactor Systems for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.